(Q40696352)

22 September 2017

title

The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge (English)

1 reference

22 September 2017

author name string

Rakel López de Maturana

series ordinal

1

1 reference

22 September 2017

Dan Donnelly

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

530

1 reference

22 September 2017

issue

1-3

1 reference

22 September 2017

page(s)

244-248

1 reference

Glucagon-like peptide-1 7-36: a physiological incretin in man.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

New drug targets for type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Characterization of glucagon-like peptide-1 receptor-binding determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

A highly sensitive adenylate cyclase assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

A simple method for the determination of affinity and binding site concentration in receptor binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Insulinotropic glucagonlike peptide-I(7-37)/(7-36)amide A new incretin hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

High potency antagonists of the pancreatic glucagon-like peptide-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2802%2903492-0

10.1016/S0014-5793(02)03492-0

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference